Skip to main content
. Author manuscript; available in PMC: 2010 May 11.
Published in final edited form as: Vaccine. 2009 Mar 13;27(21):2760–2767. doi: 10.1016/j.vaccine.2009.03.003

Figure 6. Acyclovir sensitivity of HSV-1 KOS WT, d106, and d106S viruses.

Figure 6

One hundred plaque-forming units (PFUs) of HSV-1 KOS, d106 or d106S virus were plated on E-11 cells, and the cultures were incubated with the indicated concentrations of acyclovir. The mean number of plaques formed in each concentration of acyclovir was divided by the mean number of plaques in the absence of acyclovir, and the results were expressed as percent of control.